Statistics
Total Visits
Views | |
---|---|
Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1-9 years: two phase 2 randomised, controlled, observer-blinded studies. | 87 |
Total Visits per Month
December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | |
---|---|---|---|---|---|---|---|
Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1-9 years: two phase 2 randomised, controlled, observer-blinded studies. | 1 | 0 | 0 | 5 | 7 | 30 | 1 |
File Downloads
Views |
---|
Top Country Views
Views | |
---|---|
United States | 20 |
Hong Kong SAR China | 12 |
Singapore | 10 |
China | 6 |
Vietnam | 6 |
Belgium | 5 |
Argentina | 3 |
Australia | 3 |
Ireland | 3 |
France | 2 |
Top City Views
Views | |
---|---|
Hanoi | 6 |
Singapore | 6 |
Ashburn | 5 |
Brussels | 5 |
Boardman | 3 |
Central | 2 |
Clonee | 2 |
Maurepas | 2 |
Melbourne | 2 |
Vitória da Conquista | 1 |